• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prehosp Disaster Med . Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series

tetano

Editor, Senior Moderator
Prehosp Disaster Med


. 2020 Nov 17;1-13.
doi: 10.1017/S1049023X20001466. Online ahead of print.
Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections, Case Series


Miki Goldenfeld[SUP] 1 [/SUP], Ran Nir-Paz[SUP] 2 [/SUP], Gadi Segal[SUP] 3 [/SUP], Elhanan Bar-On[SUP] 4 [/SUP], Ella Mendelson[SUP] 5 [/SUP], Michal Mandelboim[SUP] 5 [/SUP], Dana G Wolf[SUP] 6 [/SUP], Edith M Marom[SUP] 7 [/SUP], Tomer Israely[SUP] 8 [/SUP], Hagit Achdout[SUP] 8 [/SUP], Galia Rahav[SUP] 9 [/SUP], W P Hanage[SUP] 10 [/SUP], Gili Regev-Yochay[SUP] 1 [/SUP]



Affiliations

Abstract

Up until now, there is much debate about the role of asymptomatic patients and pauci-symptomatic patients in severe acute respiratory syndrome novel coronavirus 2 (SARS-CoV-2) transmission, and little is known about the kinetics of viral ribonucleic acid (RNA) shedding in these populations. This article aims to describe key features and the nature of asymptomatic and pauci-symptomatic SARS-CoV-2 infected patients. The cohort consisted of six participants, three pairs, which were infected with SARS-CoV-2 during February 2020 on board the Diamond Princess. Of the six confirmed (reverse transcription polymerase chain reaction [RT-PCR]) cases, four were initially diagnosed in Japan and two upon their arrival to Israel. Duration of infection was between four days and up to 26 days. Of the six patients, three were completely asymptomatic and the others were pauci-symptomatic. All five patients in whom a computerized tomography (CT) scan was performed had lung pathology. In one patient, infectivity was tested using cell culture and a cytopathic effect was demonstrated. A serology test was performed in three of the patients and all three had a positive immunoglobulin G (IgG) four to eight weeks after disease onset. This case series demonstrates that asymptomatic and pauci-symptomatic patients may play a role in infection transmission by demonstrating probable transmission among asymptomatic spouses and by demonstrating a viable virus via a cell culture. Additionally, asymptomatic and pauci-symptomatic patients can have lung pathology and developing IgG antibodies.

Keywords: COVID-19; SARS-CoV-2; asymptomatic; case series; pauci-symptomatic.
 
Back
Top Bottom